1. Ketut Suwita. Penyakit Ginjal Kronik. Aru WS, Bambang S, Idrus A,
Marcellus SK, Siti S, editor. Buku Ajar Ilmu Penyakit Dalam. Ed 4 Jilid I. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2007. Hlm- 570-3. 2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, 2007. Prevelance of chronic kidney disease in the United States. JAMA. 298: 2038-2047. 3. Levey, A.S., Steven, L.A., Schmid, C.H., Zhang, y., Castro, A.F., Feldman, H.I., Kusek, J.W., Eggers, P., Lente, F.V., Greene, T., and Coresh, J. 2009. A new equation to estimate glomerular filtration rate. Ann Intern Med. 150(9): 604-12. 4. Editorial. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, Classification, and Stratification. 2011. 5. Arora P et al. Chronic Kidney Disease. Emedicine Medscape. 2019 6. Sudoyo, A.W., Setiyohadi, B., Alwi, I., Sumadibrata, M., dan Setiati. 2006. Buku Ajar Ilmu Penyakit Dalam. Edisi IV, Jilid III. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FKUI. 7. Nitta, K. 2011. Review Article: Possible Link Between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovaskular Disease. Cardiol Res Pract. 10: 1-7. 8. Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Kuzicka, M., et al. 2008. Guidelines for the management of chronic kidney disease. CMAJ 179(11): 1154-1162. 9. Chan, M.R., Dall, A.T., Fletcher, K.E., Lu, N., dan Trivedi, H. 2007. Outcomes in patients with chronic kidney disease referred late to nephrologists a meta-analysis. Am J Med. 120(12): 1063-70. 10. Prodjosudjadi, W. 2006. Incidence, prevalence, treatment and cost of end- stage renal disease in Indonesia. Ethnic Dis. 16: S214-S216. 11. Murd et al Autogenous versus prosthetic vascular access for haemodialysis: A systematic review and meta-analysis J Vasc Surg 2008; 48:34S-47S. 12. Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI,Thomas C, Hemmelgarn BR, Craig JC, Manns B, Tonelli M, Strippoli GF, James MT Associations between haemodialysis access type and clinical outcomes: A systematic review. J Am Soc Nephrol 2013; 24: 465–473 13. Yeh L, Chiu S, Lai P. the impact of vascular access types on hemodialysis patient long-term survival. Scientific reports.2019.Vol 9:10708 14. Tey R. Vascular access for haemodialysis: an unresolved issue. Nefrologia 2010;30(3):280-7 15. Hoggard J, Saad T, Schon D et al. guidelines for venous access in patients with chronic kidney disease. Seminars in Dialysis, Vol 21, No 2 (March– April) 2008 pp. 186–191 16. Siddiqui M, Santos D, Ashraff S. haemodialysis and vasculae access in the end stage kidney disease. European Journal of Clinical and Biomedical Sciences. Vol. 3, No. 1, 2017, pp. 1-6. 17. Tey R, Lopez J. Update on vascular access for hemodialysis: The new Spanish Clinical Guideline Nefrologia. 2018;38:353–354 18. Woo K, Lok C. New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients? Clin J Am Soc Nephrol. 2016 19. Sahasrabudhe P, Dighe T. Retrospective analysis of 271 arteriovenous fistulas as vascular access for hemodialysis. Indian Journal of Nephrology. May 2013. Vol 23:3